CHAPEL HILL, N.C., Dec. 16, 2013 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that it will provide an update on the clinical development of solithromycin (CEM-101) and TAKSTA™ (CEM-102). Prabhavathi Fernandes, Ph.D., president and chief executive officer of Cempra will host a conference call and webcast at 4:30 p.m. EST, today, Dec. 16, 2013.
Help employers find you! Check out all the jobs and post your resume.
